<DOC>
	<DOCNO>NCT01953393</DOCNO>
	<brief_summary>Type 2 diabetes characterize increased insulin resistance impaired insulin secretion . In addition , type 2 diabetes associate low grade inflammation indicate increased level proinflammatory cytokine TNF-α . TNF-α previously show impair peripheral insulin signal vitro vivo . However , unclear whether TNF-α may also affect endogenous glucose production ( EGP ) fast glucose stimulate insulin secretion ( GSIS ) vivo . We hypothesize low dose TNF-α would increase EGP attenuate GSIS . Recombinant human TNF-α placebo infuse healthy , non-obese non-diabetic young men ( n=10 ) 4-hour basal period follow intravenous glucose tolerance test ( IVGTT ) .</brief_summary>
	<brief_title>The Acute Effects Low-dose TNF-α Glucose Metabolism β-cell Function Humans</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<criteria>Healthy men Age 2035 obesity ( BMI &gt; 25 ) diabetes chronic disease</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>September 2013</verification_date>
</DOC>